ArticleThe Journal of clinical investigation2021

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.

Arne Sattler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.